Bio-Techne Corp - Common Stock (NQ:TECH)

72.40 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bio-Techne Corp - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Bio-Techne (TECH) Reports Earnings Tomorrow: What To Expect

February 02, 2026

Life sciences company Bio-Techne (NASDAQ:TECH) will be announcing earnings results this Wednesday before market open. Here’s what to look for.

Via StockStory

Topics Artificial Intelligence

3 Unpopular Stocks That Concern Us

January 28, 2026

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other...

Via StockStory

3 Cash-Producing Stocks That Fall Short

January 22, 2026

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

Via StockStory

Picks and Shovels of the Bio-Revolution: A Deep Dive into Bio-Techne Corporation (TECH)

January 22, 2026

Today’s Date: January 22, 2026 Introduction In the complex ecosystem of biotechnology, where breakthrough drugs often dominate the headlines, the companies providing the fundamental tools—the "picks...

Via Finterra

Topics Regulatory Compliance Supply Chain

Earnings Scheduled For November 5, 2025 ↗

November 05, 2025

Via Benzinga

An Overview of Bio-Techne's Earnings ↗

November 04, 2025

Via Benzinga

1 High-Flying Stock for Long-Term Investors and 2 That Underwhelm

January 20, 2026

Expensive stocks often command premium valuations because the market thinks their business models are exceptional. However, the downside is that high expectations are already baked into their prices,...

Via StockStory

Movers and shakers in today's after-hours session for S&P500 stocks? ↗

January 19, 2026

Via Chartmill

3 Small-Cap Stocks We Keep Off Our Radar

January 06, 2026

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a...

Via StockStory

3 Reasons to Avoid TECH and 1 Stock to Buy Instead

January 05, 2026

Bio-Techne’s 21% return over the past six months has outpaced the S&P 500 by 10.9%, and its stock price has climbed to $62.36 per share. This performance may have investors wondering how to approach...

Via StockStory

Topics Stocks Supply Chain

1 S&P 500 Stock with Exciting Potential and 2 We Question

January 04, 2026

While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural...

Via StockStory

Topics Stocks

Research Tools & Consumables Stocks Q3 Results: Benchmarking Bio-Techne (NASDAQ:TECH)

December 30, 2025

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Bio-Techne (NASDAQ:TECH) and...

Via StockStory

Topics Economy

Bio-Techne Corp (NASDAQ:TECH) Passes the Caviar Cruise Screen for Quality Investors ↗

December 16, 2025

Bio-Techne Corp (TECH) exemplifies quality investing with high returns on capital, strong cash flow, and a robust balance sheet for long-term growth.

Via Chartmill

3 High-Flying Stocks We Find Risky

December 01, 2025

Expensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match. The flip side though is that these lofty expectations make them particularly...

Via StockStory

Wall Street Holds Its Breath: Hopes for Fed Rate Cuts Fuel Volatility Amidst Economic Crossroads

December 04, 2025

New York, NY – December 4, 2025 – Wall Street is currently navigating a period of palpable tension and cautious optimism, with market volatility predominantly fueled by the fervent anticipation of...

Via MarketMinute

Topics Bonds Economy World Trade

3 Profitable Stocks with Questionable Fundamentals

December 01, 2025

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Via StockStory

Uncover the latest developments among S&P500 stocks in today's session. ↗

November 26, 2025

Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session.

Via Chartmill

Natera, GoodRx, and Bio-Techne Shares Are Soaring, What You Need To Know

November 24, 2025

A number of stocks jumped in the afternoon session after reports revealed the Trump administration considered extending the Affordable Care Act (ACA) subsidies.

Via StockStory

Topics Economy Government

3 Healthcare Stocks We Steer Clear Of

November 24, 2025

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have not only realized strong financial performance but...

Via StockStory

Topics Stocks

Envista, Alignment Healthcare, LifeStance Health Group, Avantor, and Bio-Techne Shares Are Soaring, What You Need To Know

November 21, 2025

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated...

Via StockStory

Topics Earnings Economy

What's going on in today's session: S&P500 movers ↗

November 20, 2025

Curious about the S&P500 stocks that are in motion on Thursday? Join us as we explore the top movers within the S&P500 index during today's session.

Via Chartmill

Agilent Technologies (NYSE: A) Declares Quarterly Dividend, Signaling Continued Shareholder Value

November 19, 2025

SANTA CLARA, CA – November 19, 2025 – Agilent Technologies Inc. (NYSE: A), a global leader in life sciences, diagnostics, and applied chemical markets, today announced that its Board of Directors has...

Via MarketMinute

Topics Artificial Intelligence Economy Regulatory Compliance

Bio-Techne, Tandem Diabetes, Align Technology, DexCom, and Teleflex Shares Skyrocket, What You Need To Know

November 11, 2025

A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid...

Via StockStory

Topics Artificial Intelligence Stocks

Multimodal AI Unleashes New Era in Cancer Research: A Revolution in Diagnosis and Treatment

November 10, 2025

Recent breakthroughs in multimodal Artificial Intelligence (AI) are fundamentally reshaping the landscape of cancer research, ushering in an era of unprecedented precision in diagnosis and personalized...

Via TokenRing AI

Topics Artificial Intelligence

Bio-Techne (TECH) Q1 2026 Earnings Call Transcript ↗

November 06, 2025

Bio-Techne (TECH) Q1 2026 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Earnings Season Echoes: Navigating the Volatility of Corporate Reports

November 05, 2025

The financial markets are once again in the throes of earnings season, a period that consistently proves to be a crucible for individual stock valuations and a significant driver of broader market...

Via MarketMinute

Topics Artificial Intelligence Economy Supply Chain

These S&P500 stocks that are showing activity before the opening bell on Wednesday. ↗

November 05, 2025

The US market is yet to commence its session on Wednesday, but let's get a preview of the pre-market session and explore the top S&P500 gainers and losers driving the early market movements.

Via Chartmill

Bio-Techne Corp (NASDAQ:TECH) Shares Drop 7.7% on Q1 Earnings and Revenue Miss ↗

November 05, 2025

Bio-Techne (TECH) stock plunges after missing Q1 FY2026 revenue and EPS estimates, triggering a sharp sell-off in pre-market trading.

Via Chartmill

Bio-Techne (NASDAQ:TECH) Misses Q3 Revenue Estimates, Stock Drops

November 05, 2025

Life sciences company Bio-Techne (NASDAQ:TECH) missed Wall Street’s revenue expectations in Q3 CY2025, with sales falling 1% year on year to $286.6 million. Its non-GAAP profit of $0.42 per share was...

Via StockStory

What To Expect From Bio-Techne’s (TECH) Q3 Earnings

November 03, 2025

Life sciences company Bio-Techne (NASDAQ:TECH) will be announcing earnings results this Wednesday before market hours. Here’s what investors should know.

Via StockStory

Topics Artificial Intelligence

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.